Upper Tract Urothelial Carcinoma

• FDA approval · 2024-10-04
  FDA Approved: JELMYTO — Supplemental Application (UroGen Pharma, Inc.)

  FDA approves a supplemental application for Jelmyto (mitomycin) submitted by UroGen Pharma, Inc.

• FDA approval · 2022-09-25
  FDA Approved: JELMYTO — Supplemental Application (UroGen Pharma, Inc.)

  FDA approved a supplemental application for JELMYTO (mitomycin) by UroGen Pharma, Inc. The approval updates the product labeling and/or indi…

• FDA approval · 2021-01-14
  FDA Approved: JELMYTO — Supplemental Application (UroGen Pharma, Inc.)

  FDA approved a supplemental application for JELMYTO (mitomycin) by UroGen Pharma, Inc.